AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 27429228
Drug: Manuka honey
RxNorm normalized name: CVS Manuka Honey Wound Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manuka honey applied twice daily
Trial: 21466650
Drug: Reduced-dose tacrolimus
RxNorm normalized name: Tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Reduced-dose tacrolimus with mycophenolate mofetil
Trial: 21466650
Drug: Standard-dose tacrolimus
RxNorm normalized name: Tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard-dose tacrolimus
Trial: 16701193
Drug: Epidural with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural with bupivacaine 0.1% and fentanyl 3mug/ml
Trial: 16701193
Drug: Patient controlled
RxNorm normalized name: PATIENT CONTROLLED ANALGESIA VIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient controlled analgesia (PCA) with i.v. morphine
Trial: 3083146
Drug: Short-term MF
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-term MF chemotherapy (mitomycin C, 0.04 mg/kg + 5-fluorouracil, 5.0 mg/kg X 6, IVr)
Trial: 3083146
Drug: Long-term carmofur
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term carmofur chemotherapy (Mifurol, 6-12 mg/kg/day over 12 weeks, PO)
Trial: 3083146
Drug: Carmofur maintenance
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carmofur maintenance therapy
Trial: 10579057
Drug: Eradication therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eradication therapy consisting of metronidazole, bismuth subcitrate, and amoxicillin
Trial: 8930145
Drug: Transdermal nicotine
RxNorm normalized name: nicotine Transdermal System
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal nicotine patch (20 mg)
Trial: 8930145
Drug: Transdermal nicotine
RxNorm normalized name: nicotine Transdermal System
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal nicotine patch (30 mg)
Trial: 8930145
Drug: Transdermal nicotine
RxNorm normalized name: nicotine Transdermal System
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal nicotine patch (10 mg)
Trial: 26771445
Drug: Febuxostat (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Febuxostat (80 mg QD)
Trial: 26771445
Drug: Allopurinol (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allopurinol (300 mg QD)
Trial: 25376884
Drug: Whey-protein drink
RxNorm normalized name: whey protein hydrolysate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whey-protein drink (20 g daily plus 20 g after each PRT session) and vitamin D supplements (2000 IU/day)
Trial: 25376884
Drug: No additional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No additional powder and supplements (control group)
Trial: 20545392
Drug: Codeine 30
RxNorm normalized name: codeine 30 MG
DrugBank: Codeine (DB00318)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Codeine 30 mg b.i.d. (0900 and 1300)
Trial: 20545392
Drug: Codeine 30
RxNorm normalized name: codeine 30 MG
DrugBank: Codeine (DB00318)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Codeine 30 mg b.i.d.
Trial: 9443524
Drug: Intensive treatment
RxNorm normalized name: Head & Shoulders Intensive Treatment
DrugBank: Selenium Sulfide (DB00971)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive treatment with risperidone
Trial: 9443524
Drug: Intensive treatment
RxNorm normalized name: Head & Shoulders Intensive Treatment
DrugBank: Selenium Sulfide (DB00971)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive treatment without risperidone
Trial: 9443524
Drug: Intensive treatment
RxNorm normalized name: Head & Shoulders Intensive Treatment
DrugBank: Selenium Sulfide (DB00971)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive treatment groups (both with and without risperidone)
Trial: 8407738
Drug: Nedocromil sodium
RxNorm normalized name: Nedocromil Sodium
DrugBank: Nedocromil (DB00716)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nedocromil sodium (4 mg, three times a day)
Trial: 28203684
Drug: Crushed ticagrelor
RxNorm normalized name: Ticagrelor
DrugBank: Ticagrelor (DB08816)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Crushed ticagrelor tablets given orally
Trial: 28203684
Drug: Crushed ticagrelor
RxNorm normalized name: Ticagrelor
DrugBank: Ticagrelor (DB08816)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Crushed ticagrelor tablets given sublingually
Trial: 25440643
Drug: Control (1.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (1.8 mL/h of normal saline)
Trial: 19794940
Drug: MLG treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MLG treatment
Trial: 19794940
Drug: MLG+IVTA treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MLG+IVTA treatment
Trial: 19794940
Drug: IVTA treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVTA treatment
Trial: 9089856
Drug: bupivacaine 1
RxNorm normalized name: bupivacaine 132 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupivacaine 1 mg plus sufentanil 5 micrograms plus epinephrine 25 micrograms
Trial: 9089856
Drug: bupivacaine 1
RxNorm normalized name: bupivacaine 132 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupivacaine 1 mg plus sufentanil 5 micrograms
Trial: 26976495
Drug: Caffeine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (20 mg/kg loading dose followed by 5 mg/kg daily maintenance until the 10th day of life)
Trial: 25029955
Drug: Dulaglutide 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dulaglutide 0.25 mg
Trial: 20809193
Drug: Music therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music therapy for noisiform tinnitus
Trial: 9552064
Drug: Granulocyte colony-stimulating
RxNorm normalized name: Granulocyte colony-stimulating factor lenograstim
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granulocyte colony-stimulating factor (G-CSF) 16 microg/kg
Trial: 9552064
Drug: High-dose cyclophosphamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose cyclophosphamide (HDCTX) 6 g/m2 plus G-CSF 5 microg/kg
Trial: 7939138
Drug: Methotrexate (MTX)
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate (MTX) at an initial dose of 15 mg/week
Trial: 7939138
Drug: Methotrexate (MTX)
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate (MTX) at an initial dose of 25 mg/week
Trial: 3373405
Drug: Indomethacin (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (0.1 mg/kg) administered intravenously every 24 hours for a total of three doses
Trial: 3373405
Drug: Placebo (saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (saline solution) administered intravenously every 24 hours for a total of three doses
Trial: 3373405
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution treatment
Trial: 31849123
Drug: l-carnitine (LC)
DrugBank: Levocarnitine (DB00583)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: l-carnitine (LC) 2 g for 8 weeks
Trial: 29844808
Drug: Anti-reflux treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-reflux treatment
Trial: 20219962
Drug: Vitamin D(3)
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D(3) supplements (1200 IU/d)
Trial: 17617938
Drug: Olive oils
RxNorm normalized name: Olive Oil
DrugBank: Olive oil (DB09567)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olive oils rich in phenolic compounds
Trial: 15613438
Drug: Oral calcium
RxNorm normalized name: Coral Calcium
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral calcium administration (1 g calcium gluconate)
Trial: 15613438
Drug: Peptone loading
RxNorm normalized name: peptones
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peptone loading test (10 g protein hydrolyzed)
Trial: 11849571
Drug: midazolam 0.5
RxNorm normalized name: midazolam 0.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: midazolam 0.5 mg x kg(‐1) mixed with sodium citrate
Trial: 11849571
Drug: midazolam 0.5
RxNorm normalized name: midazolam 0.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: midazolam 0.5 mg x kg(‐1) mixed with Hawaiian fruit punch
Trial: 8873835
Drug: Amoxicillin and
RxNorm normalized name: omeprazole, amoxicillin and rifabutin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin and clavulanic acid (1.2 g i.v. every 8 hours for 3-4 days, followed by 625 mg orally every 8 hours until labor)
Trial: 1824374
Drug: Injection pen
RxNorm normalized name: Albiglutide 30 mg powder for solution for injection pen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection pen system (Nordiject) for administration of B-hGH (Norditropin)
Trial: 1824374
Drug: Syringe (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Syringe (4 IU/ml)
Trial: 1824374
Drug: Injection pen
RxNorm normalized name: Albiglutide 30 mg powder for solution for injection pen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection pen (Nordiject) (12 IU/ml)
Trial: 30567952
Drug: 9-item Morisky
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 9-item Morisky Medication Adherence Scale (MMAS-9)
Trial: 25166719
Drug: MK-5442 (2.5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MK-5442 (2.5, 5, 7.5, 10, or 15 mg)
Trial: 25166719
Drug: MK-5442 (higher
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MK-5442 (higher doses)
Trial: 18773914
Drug: Artificially sweetened
RxNorm normalized name: COLOR,ARTIFICIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artificially sweetened solutions (aspartame concentrations of 0, 0.01, 0.03, 0.08, and 0.28%)
Trial: 17635944
Drug: Hypertonic saline
RxNorm normalized name: ENTSOL Hypertonic Saline Nasal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypertonic saline infusion combined with thirsting for 17 hours
Trial: 17635944
Drug: Hypotonic saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypotonic saline infusion with iv desmopressin during free water intake
Trial: 11079257
Drug: 80 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg/day simvastatin and 2 mg folic acid/0.8 mg vitamin B12 daily (combination group)
Trial: 11079257
Drug: 80 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg/day simvastatin and placebo vitamins (simvastatin alone group)
Trial: 11079257
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg folic acid/0.8 mg vitamin B12 daily and placebo simvastatin (vitamins alone group)
Trial: 9145970
Drug: Placebo/no treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo/no treatment
Trial: 3164333
Drug: Guided tissue
RxNorm normalized name: tissue respiratory factor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guided tissue regeneration surgical treatment with teflon membrane and chlorhexidine gluconate rinses
Trial: 3164333
Drug: Control treatment
RxNorm normalized name: SALICYLIC ACID 190 mg in 1 mL TOPICAL LIQUID [Derma E Acne Blemish Control Treatment Serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control treatment procedure (not specified in detail)
Trial: 30402951
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of BBR and rosuvastatin
Trial: 25847579
Drug: Open-label Advair
RxNorm normalized name: Advair
DrugBank: Salmeterol (DB00938)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Open-label Advair 250/50 twice daily for 8 weeks followed by randomization to Advair 250/50, Flovent 250, or Advair 100/50, given 1 inhalation twice daily.
Trial: 23245760
Drug: GSK1521498 (mu-opioid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GSK1521498 (mu-opioid receptor antagonist)
Trial: 18388845
Drug: Medicare-based algorithm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medicare-based algorithm for measuring chemotherapy-related toxicities
Trial: 20578930
Drug: 0.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg/kg MPH
Trial: 15994064
Drug: 1.0 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mg/kg MPH
Trial: 14578916
Drug: Individualized treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individualized treatment strategy (IND)
Trial: 14578916
Drug: Stepwise treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stepwise treatment strategy (STEP)
Trial: 9579942
Drug: Ganaxolone (doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ganaxolone (doses ranging from 50 to 1,500 mg)
Trial: 8265871
Drug: Broad-spectrum antimicrobial
RxNorm normalized name: Sentinel Spectrum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Broad-spectrum antimicrobial agents
Trial: 8265871
Drug: Cytokines and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytokines and other biological agents
Trial: 8265871
Drug: Rational use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rational use of antibiotics
Trial: 28102582
Drug: Preventive Cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preventive Cognitive Therapy (PCT) with ADM tapering
Trial: 28102582
Drug: Preventive Cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preventive Cognitive Therapy (PCT) with maintenance ADM
Trial: 23255379
Drug: Group-based cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group-based cognitive behaviour therapy (CBT) anger management intervention facilitated by lay therapists.
Trial: 22024003
Drug: Family cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Family cognitive behavioral therapy (FCBT)
Trial: 16792052
Drug: Chlorhexidine-containing chewing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorhexidine-containing chewing gum (5 mg of chlorhexidine diacetate)
Trial: 2423783
Drug: Indoramin (average
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indoramin (average dose of 50 mg every 12 h in 11 patients)
Trial: 24083021
Drug: ALONE group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALONE group (only primary participant attended treatment)
Trial: 21931073
Drug: manidipine/delapril combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: manidipine/delapril combination (10/30 mg/d)
Trial: 21931073
Drug: delapril (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: delapril (30 mg/d)
Trial: 21931073
Drug: manidipine/delapril combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: manidipine/delapril combination
Trial: 12588384
Drug: Autologous blood
RxNorm normalized name: Banked autologous blood
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autologous blood therapy (ABT)
Trial: 10917114
Drug: Oral estradiol
RxNorm normalized name: estradiol Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral estradiol 1 mg daily
Trial: 8768844
Drug: L-692,429 (0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-692,429 (0.05 mg/kg · h) for 24 h (low dose)
Trial: 8768844
Drug: L-692,429 (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-692,429 (0.1 mg/kg · h) for 12 h, then saline for 12 h (high dose)
Trial: 8768844
Drug: GHRH (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GHRH (1 μg/kg, iv) given 30 min before the end of each 24-h treatment
Trial: 25928879
Drug: Pentaerythritol tetranitrate
RxNorm normalized name: Pentaerythritol tetranitrate
DrugBank: Pentaerythritol tetranitrate (DB06154)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentaerythritol tetranitrate (PETN) 80 mg/kg twice daily
Trial: 19958867
Drug: Elinogrel (10,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elinogrel (10, 20, 40, and 60 mg) administered as a single intravenous bolus before primary PCI
Trial: 19958867
Drug: Elinogrel (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elinogrel (all doses)
Trial: 17108847
Drug: Testosterone patch
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone patch releasing 300 microg/24 hours
Trial: 11300389
Drug: Fentanyl 10
RxNorm normalized name: FENTANYL 100MCG/HR PATCH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 10 microg x ml(‐1)
Trial: 11300389
Drug: Fentanyl combined
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fentanyl combined with ropivacaine 1 mg x ml(‐1)
Trial: 10073511
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg mifepristone
Trial: 8688400
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (600 mg and 200 mg mifepristone)
Trial: 2176947
Drug: Dopamine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopamine infusion at 10 micrograms min‐1 kg‐1
Trial: 2176947
Drug: Dopamine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopamine infusion at 5 micrograms min‐1 kg‐1
Trial: 2176947
Drug: Dopamine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopamine infusion at 2 micrograms min‐1 kg‐1
Trial: 2176947
Drug: Control (5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (5% D‐glucose infusion)
Trial: 24914549
Drug: Citalopram (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram (30 mg/day)
Trial: 17945035
Drug: Oxaliplatin 130
RxNorm normalized name: Oxaliplatin
DrugBank: Oxaliplatin (DB00526)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oxaliplatin 130 mg/m² on day 1 plus capecitabine 2000 mg/m² daily on days 1-15 (series I)
Trial: 17945035
Drug: Oxaliplatin 85
RxNorm normalized name: Oxaliplatin
DrugBank: Oxaliplatin (DB00526)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oxaliplatin 85 mg/m² on day 1 plus capecitabine 2000 mg/m² daily on days 1-15 (series II)
Trial: 8220940
Drug: naproxen 500
RxNorm normalized name: naproxen 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: naproxen 500 mg twice daily for 2 weeks
Trial: 3612776
Drug: No-treatment condition
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No-treatment condition (Control)
Trial: 29288788
Drug: Nephrostomy tract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nephrostomy tract infiltration (NTI) with 20 mL of 0.25% ropivacaine and epinephrine (n=32)
Trial: 29288788
Drug: Intercostal nerve
RxNorm normalized name: nerve growth factor
DrugBank: Nerve Growth Factor (DB12620)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intercostal nerve block with 15 mL of 0.5% ropivacaine and epinephrine (n=32)
Trial: 24767232
Drug: PAP therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PAP therapy for 18 months
Trial: 18616432
Drug: Morphine (only)
DrugBank: Morphine (DB00295)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Morphine (only)
Trial: 18616432
Drug: Morphine and
RxNorm normalized name: morphine and antispasmodics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine and hydromorphone
Trial: 15780537
Drug: Intranasal 17beta‐estradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal 17beta‐estradiol treatment (300 microg once daily)
Trial: 11975863
Drug: DHEA (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHEA (300 mg)
Trial: 8554932
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg salbutamol via nebuliser
Trial: 1824806
Drug: Doxazosin (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxazosin (mean dose 4.35 ± 0.2 mg/day)
Trial: 31072841
Drug: Exercise therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise therapy plus early reconstructive surgery
Trial: 31072841
Drug: Exercise therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise therapy plus delayed reconstructive surgery, if needed
Trial: 26411271
Drug: Atropine infusion
RxNorm normalized name: Atropine
DrugBank: Atropine (DB00572)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atropine infusion on admission.
Trial: 16380589
Drug: Oral amiodarone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral amiodarone (10 mg/kg daily) administered 6 days prior to surgery through 6 days after surgery (13 days)
Trial: 11475741
Drug: Artificial Shexiang
RxNorm normalized name: COLOR,ARTIFICIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artificial Shexiang Baoxin Pill (SXBXP)
Trial: 11475741
Drug: Natural Shexiang
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Natural Shexiang Baoxin Pill (SXBXP)
Trial: 2668784
Drug: Placebo (for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (for both drugs)
Trial: 28816728
Drug: All lens
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All lens types with any of the four care solutions
Trial: 26005839
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy (CBT) in Veterans
Trial: 18191265
Drug: Concomitant chemo
RxNorm normalized name: Chem-Star Recover
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concomitant chemo radiation treatment
Trial: 16314075
Drug: Topical anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical anesthesia first